Daily Archives: September 2, 2021

MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era

Posted on September 2, 2021 by Gastroenterology Journal

The model for end-stage liver disease (MELD) has been established as a reliable indicator of short-term survival in patients with end-stage liver disease. The current version (MELDNa), consisting of INR and serum bilirubin, creatinine, and sodium, has … Continue reading →

Posted in News | Comments Off on MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era